StreetInsider.com News Articles

Form SCHEDULE 13G CytomX Therapeutics, Filed by: Kynam Capital Management, LP

Wed, 04 Mar 2026 15:19:00 -0500

si-local-file:///var/storage/secattach/20260304/26110507.html

Form SCHEDULE 13G CytomX Therapeutics, Filed by: Kynam Capital Management, LP

Wed, 04 Mar 2026 15:19:00 -0500

si-local-file:///var/storage/secattach/20260304/26110507.html

CytomX Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026

Wed, 04 Mar 2026 08:00:00 -0500

SOUTH SAN FRANCISCO, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that it will report full year 2025 financial results on Monday, March 16, 2026, before the open of U.S. markets. Following the announcement, the Company will host a conference call and webcast at 8:00 a.m. ET / 5:00 a.m. PT.

Participants may access the live webcast of the conference call from the Events and Presentations page of CytomX’s website at https://ir.cytomx.com/events-and-presentations. Participants may register

CytomX Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026

Wed, 04 Mar 2026 08:00:00 -0500

CytomX Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026

Wed, 04 Mar 2026 08:00:00 -0500

CytomX Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026

Wed, 04 Mar 2026 08:00:00 -0500

Form SCHEDULE 13G/A CytomX Therapeutics, Filed by: ORBIMED ADVISORS LLC

Tue, 17 Feb 2026 18:24:00 -0500

si-local-file:///var/storage/secattach/20260217/26015722.html

Form SCHEDULE 13G/A CytomX Therapeutics, Filed by: ORBIMED ADVISORS LLC

Tue, 17 Feb 2026 18:24:00 -0500

si-local-file:///var/storage/secattach/20260217/26015722.html

Form SCHEDULE 13G/A CytomX Therapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC

Tue, 17 Feb 2026 16:16:00 -0500

si-local-file:///var/storage/secattach/20260217/26013103.html

Form SCHEDULE 13G/A CytomX Therapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC

Tue, 17 Feb 2026 16:16:00 -0500

si-local-file:///var/storage/secattach/20260217/26013103.html

Form SCHEDULE 13G/A CytomX Therapeutics, Filed by: FMR LLC

Thu, 05 Feb 2026 13:21:00 -0500

si-local-file:///var/storage/secattach/20260205/25953552.html

Form SCHEDULE 13G/A CytomX Therapeutics, Filed by: FMR LLC

Thu, 05 Feb 2026 13:21:00 -0500

si-local-file:///var/storage/secattach/20260205/25953552.html

Form 4 CytomX Therapeutics, For: Feb 02 Filed by: Lester Rachael

Wed, 04 Feb 2026 16:28:00 -0500

si-local-file:///var/storage/secattach/20260204/25947512.html

Form 4 CytomX Therapeutics, For: Feb 02 Filed by: Lester Rachael

Wed, 04 Feb 2026 16:28:00 -0500

si-local-file:///var/storage/secattach/20260204/25947512.html

Form 4 CytomX Therapeutics, For: Feb 02 Filed by: Chu Yu-Waye

Wed, 04 Feb 2026 16:27:00 -0500

si-local-file:///var/storage/secattach/20260204/25947479.html

Form 4 CytomX Therapeutics, For: Feb 02 Filed by: Chu Yu-Waye

Wed, 04 Feb 2026 16:27:00 -0500

si-local-file:///var/storage/secattach/20260204/25947479.html

Form 4 CytomX Therapeutics, For: Feb 02 Filed by: BELVIN MARCIA

Wed, 04 Feb 2026 16:25:00 -0500

si-local-file:///var/storage/secattach/20260204/25947457.html

Form 4 CytomX Therapeutics, For: Feb 02 Filed by: BELVIN MARCIA

Wed, 04 Feb 2026 16:25:00 -0500

si-local-file:///var/storage/secattach/20260204/25947457.html

Form 4 CytomX Therapeutics, For: Feb 02 Filed by: Ogden Christopher

Wed, 04 Feb 2026 16:24:00 -0500

si-local-file:///var/storage/secattach/20260204/25947428.html

Form 4 CytomX Therapeutics, For: Feb 02 Filed by: Ogden Christopher

Wed, 04 Feb 2026 16:24:00 -0500

si-local-file:///var/storage/secattach/20260204/25947428.html

Form 4 CytomX Therapeutics, For: Feb 02 Filed by: McCarthy Sean A.

Wed, 04 Feb 2026 16:22:00 -0500

si-local-file:///var/storage/secattach/20260204/25947390.html

Form 4 CytomX Therapeutics, For: Feb 02 Filed by: McCarthy Sean A.

Wed, 04 Feb 2026 16:22:00 -0500

si-local-file:///var/storage/secattach/20260204/25947390.html

CytomX Therapeutics (CTMX) PT Raised to $10 at Cantor Fitzgerald

Wed, 04 Feb 2026 09:51:25 -0500

Cantor Fitzgerald analyst Olivia Brayer raised the price target on CytomX Therapeutics (NASDAQ: CTMX) to $10.00 (from $6.00) while maintaining a Overweight rating.

The analyst commented, "We are raising our price target to $10 (previously $6) on our increased conviction in Varseta for colorectal cancer. We are assuming ~$700M in peak Varseta-M risk-adjusted sales, with success in both the 4L setting (45% POS) and 3L CRC (25% POS)."

CytomX Therapeutics to Present at Upcoming February Conferences

Wed, 04 Feb 2026 08:00:00 -0500

SOUTH SAN FRANCISCO, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that management will participate in the following conferences in February.

Guggenheim Emerging Outlook: Biotech Summit 2026
Date: Wednesday, February 11, 2026
Fireside Chat: 4:30 p.m. ET
Location: New York, NY

World ADC London 2026
Date: Wednesday, February 25, 2026
Presentation: 5:00 p.m. GMT
Location: London, UK

Additional information can be found on the Events and Presentations page of CytomX’s website at www.cytomx.com.

About CytomX Therapeutics,

CytomX Therapeutics to Present at Upcoming February Conferences

Wed, 04 Feb 2026 08:00:00 -0500

SOUTH SAN FRANCISCO, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that management will participate in the following conferences in February.

Guggenheim Emerging Outlook: Biotech Summit 2026
Date: Wednesday, February 11, 2026
Fireside Chat: 4:30 p.m. ET
Location: New York, NY

World ADC London 2026
Date: Wednesday, February 25, 2026
Presentation: 5:00 p.m. GMT
Location: London, UK

Additional information can be found on the Events and Presentations page of CytomX’s website at www.cytomx.com.

About CytomX Therapeutics,